Overview

Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy

Status:
Enrolling by invitation

Trial end date:
2027-02-26

Target enrollment:

Participant gender:

Summary

the purpose of this clinical trial is to assess the efficacy and safety of Orotic Acid Carnitine Complex Capsules (Godex®) in comparison to a placebo control group in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

Phase:

Phase 3

Details

Lead Sponsor:

Yoon Jun Kim

Collaborator:

Celltrion Pharm, Inc.